StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories stock-Based Compensation Expense ($M) ($M)

Postgres DB financial_values + XBRL

QuarterlyAnnual
Latest, FY2025
664
Period ended Dec 31, 2025
Change on a year earlier
-1.3%
673 in FY2024
History
19 years
Since FY2007
Sources
15
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedStock-Based Compensation Expense ($M) ($M)Year on yearSource
FY2025Dec 31, 2025664-1.3%Form 10-K (filed 2026-02-20) ↗
FY2024Dec 31, 2024673+4.5%Form 10-K (filed 2025-02-21) ↗
FY2023Dec 31, 2023644-6.0%Form 10-K (filed 2024-02-16) ↗
FY2022Dec 31, 2022685+7.0%Form 10-K (filed 2023-02-17) ↗
FY2021Dec 31, 2021640+17.2%Form 10-K (filed 2022-02-18) ↗
FY2020Dec 31, 2020546+5.2%Form 10-K (filed 2021-02-19) ↗
FY2019Dec 31, 2019519+8.8%Form 10-K (filed 2020-02-21) ↗
FY2018Dec 31, 2018477+17.5%Form 10-K (filed 2019-02-22) ↗
FY2017Dec 31, 2017406+31.0%Form 10-K (filed 2018-02-16) ↗
FY2016Dec 31, 2016310+6.2%Form 10-K (filed 2017-02-17) ↗
FY2015Dec 31, 2015292+18.7%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 2014246-6.1%Form 10-K (filed 2015-02-27) ↗
FY2013Dec 31, 2013262-39.5%Form 10-K (filed 2014-02-21) ↗
FY2012Dec 31, 2012433+13.1%Form 10-K (filed 2014-02-21) ↗
FY2011Dec 31, 2011383-1.0%Form 10-K (filed 2014-02-21) ↗
FY2010Dec 31, 2010387+5.7%Form 10-K (filed 2011-02-18) ↗

Cite this data

StockData. (2026). Abbott Laboratories Stock-Based Compensation Expense ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-cf-sbc

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.